2-178625396-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP2
The NM_001267550.2(TTN):c.44425G>A(p.Val14809Met) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000646 in 1,546,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001267550.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.44425G>A | p.Val14809Met | missense_variant, splice_region_variant | 241/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.44425G>A | p.Val14809Met | missense_variant, splice_region_variant | 241/363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151510Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000645 AC: 9AN: 1395310Hom.: 0 Cov.: 30 AF XY: 0.00000578 AC XY: 4AN XY: 691620
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151510Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73938
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 03, 2020 | This sequence change replaces valine with methionine at codon 14809 of the TTN protein (p.Val14809Met). Conservation data is not available for this valine residue. There is a small physicochemical difference between valine and methionine. This variant also falls at the first nucleotide of exon 241 of the TTN coding sequence, which is part of the consensus splice site for this exon. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a TTN-related disease. Experimental studies and protein prediction algorithms are not available for this variant, and the functional significance of this missense variant is currently unknown. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. In summary, this is a novel missense change with uncertain impact on splicing and protein function. It has been classified as a Variant of Uncertain Significance. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1838244:Tibial muscular dystrophy;C1858763:Dilated cardiomyopathy 1G;C1861065:Hypertrophic cardiomyopathy 9;C1863599:Myopathy, myofibrillar, 9, with early respiratory failure;C2673677:Early-onset myopathy with fatal cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 17, 2021 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 17, 2019 | The p.V5744M variant (also known as c.17230G>A), located in coding exon 68 of the TTN gene, results from a G>A substitution at nucleotide position 17230. The valine at codon 5744 is replaced by methionine, an amino acid with highly similar properties. This change occurs in the first base pair of coding exon 68. The splice prediction software does not produce a reliable prediction for the nearby native splice acceptor site. This amino acid position is well conserved in available vertebrate species. In addition, the amino acid change is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at